GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Taiyen Biotech Co Ltd (TPE:1737) » Definitions » Net Income From Continuing Operations

Taiyen Biotech Co (TPE:1737) Net Income From Continuing Operations : NT$327 Mil (TTM As of Sep. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Taiyen Biotech Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Taiyen Biotech Co's net income from continuing operations for the three months ended in Sep. 2024 was NT$103 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was NT$327 Mil.

Taiyen Biotech Co Net Income From Continuing Operations Historical Data

The historical data trend for Taiyen Biotech Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiyen Biotech Co Net Income From Continuing Operations Chart

Taiyen Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 428.55 464.04 509.92 530.59 329.12

Taiyen Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 184.08 -9.10 120.27 112.52 103.06

Taiyen Biotech Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$327 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiyen Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Taiyen Biotech Co Ltd (TPE:1737) » Definitions » Net Income From Continuing Operations
Comparable Companies
ROCO:6523 ROCO:6703 TPE:6504 TPE:4190 TPE:9919 TPE:1730 TPE:6790 TPE:6666 TPE:1817 TPE:6671 PG XPAR:OR LSE:ULVR BOM:500696 CL LSE:RKT EL KMB KVUE XTER:BEI
Traded in Other Exchanges
N/A
Address
No. 297, Section 1, Chien-Kang Road, South District, Tainan, TWN
Website
https://www.tybio.com
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.

Taiyen Biotech Co Headlines

No Headlines